File 001 · Category Openers

Record 062 · Health · 2020

20.62.H

Pfizer–BioNTech COVID-19 Vaccine (Comirnaty)

Pfizer / BioNTech

Type of vaccine for humans

A 10-month shot that validated mRNA as a platform and bent a pandemic curve.

The first authorized mRNA vaccine for a pandemic.

95% efficacy in Phase 3. Emergency use Dec 2020. Billions of doses with Moderna's Spikevax. Platform now being pointed at cancer and flu.

Filed notes

  • Modified-nucleoside mRNA + LNP
  • Compressed clinical + manufacturing wartime scale

Units. Billions of doses globally across mRNA COVID vaccines

SIC

2836

Biological Products, Except Diagnostic Substances

NAICS

325414

Biological Product (except Diagnostic) Manufacturing

Official

Also in this file